EPCAM and neoplasm: In an in vitro study, Scott et al. have shown that OVs with implemented CD3 × EpCAM TCE construct effectively promote T-cell anti-tumor activity, without an antagonistic relationship between the T-cell population and virulence, which was a suspected issue [150].